James Harris

The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

J. E. Curtis, E. M. Hersh, James Harris et al. · PubMed · 1970 · 116 citations

Life Sciences, Immunology, Oncology +11

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.

F J Cummings, Robert J. Gray, D C Tormey et al. · Journal of Clinical Oncology · 1993 · 113 citations

Medicine, Geriatric Medicine, Oncology +16

Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.

James A. Neidhart, Stewart A. Anderson, James Harris et al. · Journal of Clinical Oncology · 1991 · 105 citations

Medicine, Oncology, Pharmacology +16

5-lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death

K.M. Anderson, Thomas M. Seed, Michele D. Vos et al. · The Prostate · 1998 · 97 citations

Life Sciences, Cell Biology, Pharmacology +15

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

J. McMannis, Richard I. Fisher, Stephen P. Creekmore et al. · The Journal of Immunology · 1988 · 79 citations

Life Sciences, Immunology, Oncology +9